Quality Compounder

556 tickers in this investment thesis
Ranks this page's recent reports by score.
ExlService Holdings, Inc.
EXLS·Technology
S ★★★★★Strong Buy
Current$41.12
Target$48.60
Return+18.2%
Oct 30, 2026

ExlService combines profitable enterprise data and AI growth with high returns on capital and an attractive historical valuation, although AI-driven outsourcing disruption and acquisition execution remain meaningful risks.

Score
85
PJT Partners Inc.
PJT·Financials
B ★★★Hold
Current$151.97
Target$170.00
Return+11.9%
Oct 30, 2026

PJT Partners combines a respected advisory franchise, expanding profitability, and substantial repurchase capacity, but transaction cyclicality, compensation costs, and a demanding earnings-growth hurdle limit its immediate upside.

Score
74
Boyd Gaming Corporation
BYD·Consumer Discretionary
A ★★★★Buy
Current$72.43
Target$83.93
Return+15.9%
Oct 30, 2026

Boyd Gaming offers established regional casino cash flows, aggressive share repurchases, and attractive normalized earnings valuation, but Las Vegas tourism weakness and elevated capital spending could delay margin recovery.

Score
80
Morningstar, Inc.
MORN·Financials
A ★★★★Buy
Current$222.54
Target$243.20
Return+9.3%
Oct 30, 2026

Morningstar combines defensible financial-data franchises, high returns on capital, and expanding cash generation at a reasonable valuation, although AI competition, uneven segment growth, and acquisition-related leverage remain material risks.

Score
84
Armstrong World Industries, Inc.
AWI·Industrials
A ★★★★Buy
Current$165.95
Target$180.00
Return+8.5%
Oct 30, 2026

Armstrong combines a durable, high-return commercial ceiling franchise with faster-growing architectural specialties and shareholder-friendly capital allocation, although construction cyclicality and inflation could constrain margins and cash conversion.

Score
77
Chemed Corporation
CHE·Healthcare
B ★★★Hold
Current$541.92
Target$588.00
Return+8.5%
Oct 30, 2026

Chemed combines durable hospice demand, strong capital returns, and improving VITAS profitability, but Medicare reimbursement exposure, Roto-Rooter margin pressure, and demanding cash-flow valuation constrain near-term upside.

Score
74
A. O. Smith Corporation
AOS·Industrials
A ★★★★Buy
Current$63.49
Target$69.40
Return+9.3%
Oct 30, 2026

A. O. Smith offers strong cash conversion, durable replacement demand and shareholder returns at an attractive historical valuation, although weak residential volumes and execution risks surrounding its China exit constrain growth.

Score
82
Check Point Software Technologies Ltd.
CHKP·Technology
A ★★★★Buy
Current$153.50
Target$169.20
Return+10.2%
Oct 30, 2026

Check Point combines durable cybersecurity subscriptions, strong free cash flow, and an attractive historical valuation discount, but slow consolidated growth and intensifying cloud-native competition may constrain its earnings recovery.

Score
82
GATX Corporation
GATX·Industrials
B ★★★Hold
Current$180.47
Target$203.40
Return+12.7%
Oct 30, 2026

GATX offers durable railcar leasing cash flows and earnings growth from its enlarged fleet, but high leverage, heavy reinvestment needs, and slowing lease-rate increases limit its risk-adjusted upside.

Score
73
GE HealthCare Technologies Inc.
GEHC·Healthcare
A ★★★★Buy
Current$76.42
Target$84.63
Return+10.7%
Oct 30, 2026

GE HealthCare combines a durable medical imaging franchise with expanding diagnostics and software earnings at a moderate valuation, although acquisition integration and hospital capital spending cycles could constrain returns.

Score
82
Chipotle Mexican Grill, Inc.
CMG·Consumer Discretionary
B ★★★Hold
Current$31.28
Target$36.18
Return+15.7%
Oct 30, 2026

Chipotle combines a powerful fast-casual brand, strong capital returns, and a substantial restaurant expansion runway with a historically compressed valuation, but persistent margin pressure threatens earnings recovery.

Score
74
Crane Company
CR·Industrials
B ★★★Hold
Current$205.81
Target$226.80
Return+10.2%
Oct 30, 2026

Crane combines durable aerospace franchises, specialized industrial technology, and improving earnings momentum, but its premium valuation and acquisition integration risks limit the margin of safety.

Score
70